Reacción #91247

ord-8029d151167847a691c158262a2a8087

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    Otroto react sequentially in the same manner as in Steps A and B of Example 1

Procedimiento

2-Chloromethyl-6-cyclopentylsulfanyl-pyridine (37 mg, 0.16 mmol) obtained in Step C of Preparation Example 27 and 3-(3-chloro-4-hydroxy-phenyl)-2-methyl-propionic acid ethyl ester (43 mg, 0.17 mmol) obtained in Step B of Preparation Example 46 were used to react sequentially in the same manner as in Steps A and B of Example 1 to obtain the title compound (51 mg, 85%).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US09447044B2uspto-grants-2016_09